Total Cost of Care: — Targeted Therapy vs Chemotherapy

Not always. The answer depends on whether an approved generic or biosimilar is available and whether your regimen is covered by a scheme. Some older targeted drugs now have generics that cost less per month than a branded chemotherapy cycle. What is consistently true is that branded targeted therapy without any scheme or generic coverage is usually far more expensive than chemotherapy. A counsellor can compare the actual numbers for your specific drugs, which is the only comparison that matters for your situation.

PMJAY covers some targeted agents, but not all. The scheme uses a package-based system, and the formulary is updated periodically. Whether your specific drug is included depends on the current list and the empanelment status of your treatment centre. The fastest way to find out is to ask the financial counsellor at your centre to check your drug against the current PMJAY package list. This takes a few minutes and removes the uncertainty.

Targeted therapy continues as long as it is working and you are tolerating it. For some cancers, that means one to two years. For others, it may be considerably longer. This is the main reason the total cost of targeted therapy can exceed that of a defined chemotherapy course even when the monthly price appears similar — there is no fixed end date. Your oncologist can give you an honest assessment of likely duration for your specific situation, which lets the counsellor model the total cost more realistically.

Tell your counsellor and your oncologist directly. Drug manufacturer patient assistance programmes, state cancer relief funds, and charitable foundations provide support for patients who fall outside the government schemes. Some require income documentation that a counsellor can help you prepare. Being specific about what you cannot afford also lets your oncologist discuss whether an equally effective regimen exists at a lower cost — this conversation should happen openly rather than be avoided.

A drug approved by CDSCO has passed bioequivalence standards, meaning it must demonstrate the same effect in the body as the original. Your oncologist will confirm whether an approved generic is clinically suitable for your specific situation. Not all targeted therapy drugs have approved generics yet. Some that are available informally have not gone through CDSCO review — ask your treating team to confirm the approval status of any drug proposed as a substitute before switching.

Most standard Indian health insurance policies cover hospitalisation and day care, which includes IV targeted agents given in a day care setting. Oral targeted therapy tablets taken at home fall outside most standard policies unless the plan includes an oncology rider or critical illness cover. Check your policy for the terms 'oral chemotherapy', 'targeted therapy', and 'outpatient cancer drugs'. Ask your insurer for written pre-authorisation confirmation for your specific regimen before assuming coverage.